Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Eight presentations at the RSNA on EchoGen

Dec. 4, 1996

Eastern European approval for Zila's oral cancer diagnostic

Dec. 4, 1996

Sorin to market Bard diagnostic test

Nov. 29, 1996

Cancer diagnostic based on p53 offered for licensing

Nov. 28, 1996

Diagnostic kits for beta-thalassemia available for licensing

Nov. 28, 1996

Cortecs, Inflazyme collaborate on tests for TB

Nov. 28, 1996

Asian distribution agreement signed for Advanced Magnetics' liver contrast agent

Nov. 28, 1996

Trinity Biotech obtains license option for hepatitis A antigens

Nov. 27, 1996

New biochemical marker for Alzheimer's disease identified

Nov. 27, 1996

Diagnostic kit for cystic fibrosis offered for licensing

Nov. 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.